Literature DB >> 23182459

Heterogeneity of pregnancy outcomes and risk of LGA neonates in Caucasian females according to IADPSG criteria for gestational diabetes mellitus.

E Disse1, J Graeppi-Dulac, G Joncour-Mills, O Dupuis, C Thivolet.   

Abstract

OBJECTIVE: The International Association of Diabetes and Pregnancy Study Group (IADPSG) guidelines for gestational diabetes mellitus (GDM) diagnosis determines that fasting, 1-h and 2-h glucose values may contribute independently to adverse outcomes. However, given the different physiological bases of impaired fasting glucose (IFG) and impaired glucose tolerance (IGT), differences in pregnancy outcomes are to be expected. This study aimed to determine whether classification of GDM women according to glucose homoeostasis results in heterogeneity in maternal and/or fetal outcomes.
MATERIAL AND METHODS: Of the 75 pregnant women included after a 75-g 2-h OGTT performed between weeks 24-32 of gestation as per WHO criteria, 55 were classified as GDM (16 with IFG and 39 with IGT) according to IADSPG criteria. Their anthropometric and metabolic characteristics were compared with those of non-GDM women with IFG or IGT. Maternal and neonatal outcomes were prospectively recorded for each group.
RESULTS: GDM women with IFG, including isolated IFG and combined IFG+IGT, were significantly heavier, had higher leptin values and were more frequently multiparous than GDM women with isolated IGT. HOMA-IR was significantly higher when fasting glucose was impaired. There were no significant differences in maternal outcomes according to metabolic status. In addition, large for gestational age (LGA) neonates were significantly seen more often in the IFG group. Fasting glucose was significantly associated with LGA independently of BMI and 2-h OGTT glucose. The>5.1mmol/L cut-off value for fasting glucose was highly predictive of delivery of LGA infants.
CONCLUSION: IFG in GDM women was associated with increases in BMI, fat mass and hepatic insulin resistance. Delivery of LGA neonates was more frequent when fasting glycaemia was increased during the third trimester of pregnancy, and was independent of BMI and 2-h OGTT glucose values.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23182459     DOI: 10.1016/j.diabet.2012.09.006

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  9 in total

1.  Gestational diabetes mellitus: different management strategies should be adopted for different subsets of patients diagnosed by oral glucose tolerance test.

Authors:  Maria Joana Santos; Vera Fernandes
Journal:  Endocrine       Date:  2018-08-07       Impact factor: 3.633

2.  Role of maternal glucose metabolism in the association between maternal BMI and neonatal size and adiposity.

Authors:  Chloe Andrews; Carmen Monthé-Drèze; David A Sacks; Ronald C W Ma; Wing Hung Tam; H David McIntyre; Julia Lowe; Patrick Catalano; Sarbattama Sen
Journal:  Int J Obes (Lond)       Date:  2020-11-08       Impact factor: 5.095

3.  Disproportionate body composition and neonatal outcome in offspring of mothers with and without gestational diabetes mellitus.

Authors:  Martina Persson; Helena Fadl; Ulf Hanson; Dharmintra Pasupathy
Journal:  Diabetes Care       Date:  2013-11       Impact factor: 19.112

4.  The Relationship between Maternal Gestational Impaired Glucose Tolerance and Risk of Large-for-Gestational-Age Infant: A Meta-Analysis of 14 Studies.

Authors:  Hai Qing Wang; Han Lin Lai; Yi Li; Qi Fei Liu; Shuang Hu; Li Li
Journal:  J Clin Res Pediatr Endocrinol       Date:  2016-04-18

5.  Single Fasting Plasma Glucose Versus 75-g Oral Glucose-Tolerance Test in Prediction of Adverse Perinatal Outcomes: A Cohort Study.

Authors:  Songying Shen; Jinhua Lu; Lifang Zhang; Jianrong He; Weidong Li; Niannian Chen; Xingxuan Wen; Wanqing Xiao; Mingyang Yuan; Lan Qiu; Kar Keung Cheng; Huimin Xia; Ben Willem J Mol; Xiu Qiu
Journal:  EBioMedicine       Date:  2017-01-18       Impact factor: 8.143

6.  Pregnancy outcomes according to the definition of gestational diabetes.

Authors:  Sanna Koivunen; Matti Viljakainen; Tuija Männistö; Mika Gissler; Anneli Pouta; Risto Kaaja; Johan Eriksson; Hannele Laivuori; Eero Kajantie; Marja Vääräsmäki
Journal:  PLoS One       Date:  2020-03-05       Impact factor: 3.240

7.  Association between neonatal hyperbilirubinemia and hypoglycemia in Chinese women with diabetes in pregnancy and influence factors.

Authors:  Jing He; Jiayang Song; Zhijie Zou; Xiaoxiao Fan; Ruixue Tian; Jingqi Xu; Yu Yan; Jinbing Bai; Zhen Chen; Yanqun Liu; Xiaoli Chen
Journal:  Sci Rep       Date:  2022-10-10       Impact factor: 4.996

Review 8.  Biomarkers for Macrosomia Prediction in Pregnancies Affected by Diabetes.

Authors:  Sofia Nahavandi; Jas-Mine Seah; Alexis Shub; Christine Houlihan; Elif I Ekinci
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-31       Impact factor: 5.555

9.  Heterogeneity of insulin resistance and beta cell dysfunction in gestational diabetes mellitus: a prospective cohort study of perinatal outcomes.

Authors:  Yingfeng Liu; Wolin Hou; Xiyan Meng; Weijing Zhao; Jiemin Pan; Junling Tang; Yajuan Huang; Minfang Tao; Fang Liu
Journal:  J Transl Med       Date:  2018-10-24       Impact factor: 5.531

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.